(87 days)
Not Found
No
The document describes a multi-technology platform for dermatological procedures using RF, IPL, and Nd:YAG laser technologies. There is no mention of AI or ML in the intended use, device description, or performance studies.
Yes
Explanation: The device is described as having indications for the temporary relief of minor muscle aches and pain, muscle spasm, improvement of local blood circulation, treatment of moderate inflammatory acne, benign pigmented and vascular lesions, warts, scars, striae, and improvement of local blood circulation, all of which are considered therapeutic applications.
No
The provided text explicitly states the intended uses of the device and its various handpieces, which are all for therapeutic or cosmetic procedures (e.g., pain relief, muscle spasm relief, treatment of lesions, hair removal, cellulite reduction, wrinkle treatment, skin resurfacing), not for diagnosing conditions.
No
The device description clearly states it is a "multi-application, multi-technology platform device" that includes a main console unit, power supply modules, cooling system, switching module, and four Handpieces. These are all hardware components, indicating it is not a software-only device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- Device Function: The Viora V30 system and its various handpieces are described as being used for dermatological procedures and treating various skin conditions, muscle aches, pain, and unwanted hair. These are all procedures performed directly on the patient's body, not on specimens taken from the body.
- Lack of Specimen Analysis: There is no mention of the device analyzing any biological specimens.
- Intended Use: The stated intended uses are all related to therapeutic or aesthetic treatments applied externally to the patient.
Therefore, the Viora V30 system falls under the category of a medical device used for external treatments, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Viora V30 system is intended for dermatological procedures.
The V-ST Handpiece is indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation.
The V-IPL Handpiece with wavelengths 415-1200nm (with 5 different filters) is indicated for the treatment of:
- Moderate inflammatory acne vulgaris.
- Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles).
- Cutaneous lesions including warts, scars and striae.
- Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte and venous malformations.
- Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen.
The V-Nd:YAG Handpiece with wavelength 1064 nm comes with 4 different applicator spot diameters: 2x4, 3.5, 5.5 and 9.5 mm.
The three smaller spot sizes (2x4, 3.5, 5.5 mm) are intended for:
- Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias), reticular veins (0.1-4.0 mm dia.) of the leg, rosacea, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas.
- Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis.
- Benign pigmented lesions such as, but not limited to: lentigos (age spots), solar lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of Ota, chloasma, verrucae, skin tags and keratosis.
- Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments.
- The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles and perioral wrinkles.
The Handpiece with a spot size of 9.5 mm is also intended for treatment of:
- Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar.
- The Handpiece with a spot size of 9.5 mm is also is intended for removal of unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen and treatment of pseudofolliculitis barbae (PFB).
The V-Form Handpiece (with BC Small, Medium and Large applicators) is indicated for delivering non thermal RF combined with massage:
- relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation and
- temporary reduction in the appearance of cellulite.
The Viora V20 and V10 systems with V-Form Handpiece (with BC Small, Medium and Large applicators) are indicated for delivering non thermal RF combined with massage:
- relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation and
- temporary reduction in the appearance of cellulite.
Product codes (comma separated list FDA assigned to the subject device)
GEX, PBX, ISA
Device Description
The Viora V30 system is a multi-application, multi-technology platform device intended for use in dermatologic procedures.
The main console unit incorporates a touch-screen control panel, power supply modules, cooling system, switching module and service panel. The system includes four Handpieces and footswitch. The V30 system is cooled by deionized water. The Viora V30 system is available with four treatment Handpieces:
- V-ST Handpiece Bi-polar radiofrequency (RF) Handpiece .
- V-IPL Handpiece Intense pulsed light (IPL) Handpiece ●
- V-ND:YAG Handpiece Long pulse neodymium-doped yttrium aluminum ● laser Handpiece
- V Form Handpiece with BC Small, BC Medium and BC Large applicators .
The V- Form BC Medium applicator is Bi-polar radiofrequency (RF) applicator.
The applicator is supported by Viora's V10, V20 and V30 systems.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Bench Tests: Bench testing demonstrated that the V30 system (with the V- Form Handpiece) and the V-Form Handpice BC Medium applicator are as safe and effective as the cleared predicate devices.
Pre-Clinical and clinical study: Since the technological parameters of the Viora V30 system with the V- Form Handpiece and of the V-Form Handpice BC Medium applicator are well within the parameters of the previously cleared V-total, V20 and V10 systems, Viora believes that animal and clinical studies are not required to determine the safety and efficacy of the V30 system with the V- Form Handpiece and of the V-Form Handpice BC Medium applicator.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
Image /page/0/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
November 18, 2016
Viora Ltd. Stella Perry Regulatory Affairs Manager 6 Hagavish Street Netanya, 4250706 IL
Re: K162363
Trade/Device Name: V30 System, V-form Handpiece Bc Medium Applicator Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology Regulatory Class: Class II Product Code: GEX, PBX, ISA Dated: October 26, 2016 Received: October 31, 2016
Dear Stella Perry:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
1
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
Jennifer R. Stevenson -A
For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
Device Name V30 system V- Form Handpiece BC Medium applicator
Indications for Use (Describe)
The Viora V30 system is intended for dermatological procedures.
The V-ST Handpiece is indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation.
The V-IPL Handpiece with wavelengths 415-1200nm (with 5 different filters) is
indicated for the treatment of:
· Moderate inflammatory acne vulgaris.
- · Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles).
- · Cutaneous lesions including warts, scars and striae.
· Benign cutaneous vascular lesions including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas, poikiloderma of Civatte and venous malformations.
· Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-tern stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen.
The V-Nd: Y AG Handpiece with wavelength 1064 nm comes with 4 different applicator spot diameters: 2x4, 3.5 .5 and 9.5 mm.
The three smaller spot sizes (2x4, 3.5, 5.5 mm) are intended for:
· Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias), reticular veins (0.1-4.0 mm dia.) of the leg, rosacea, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas.
- · Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis.
· Benign pigmented lesions such as, but not limited to: lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of Ota, chloasma, verrucae, skin tags and keratosis.
· Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments.
• The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles. The Handpiece with a spot size of 9.5 mm is also intended for treatment of:
· Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar.
• The Handpiece with a spot size of 9.5 mm is also is intended for removal of unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction in the number of hairs regrowing
when measured at 6, 9, and 12 months after the completion of a treatment of pseudofollicultis barbae (PFB).
The V-Form Handpiece (with BC Small, Medium and Large applicators) is indicated for delivering non thermal RF combined with massage:
· relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation and
· temporary reduction in the appearance of cellulite.
3
The Viora V20 and V10 systems with V-Form Handpiece (with BC Small, Medium and Large applicators) are indicated for delivering non thermal RF combined with massage:
· relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation and · temporary reduction in the appearance of cellulite.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Image /page/4/Picture/0 description: The image contains the logo for VIORA. The logo consists of a stylized infinity symbol above the word "VIORA" in a bold, sans-serif font. Below the word "VIORA" is the tagline "Shape the Future" in a smaller, lighter font.
510(k) Summary
This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of the Safe Medical Devices Act of 1990 and 21
CFR 807.92.
| Submitter Name
and Address: | Viora Ltd.
6 Hagavish Street
Netanya, Israel 4250706
Israel |
|------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Stella Raizelman Perry
RA Manager
Email: Stella@vioramed.com
Phone Number: +972 9955 1344
Fax Number: +972 9955 1345 |
| Establishment
Registration
Number: | 3005695724 |
| Date Prepared: | August 17, 2016 |
| Device Trade
Name(s): | V30 system, V-Form Handpiece BC Medium Applicator |
| Device Common
Name: | Multi application RF, IPL and Laser device, RF based
applicator |
| Classification: | Name: Laser surgical instrument for use in general and plastic
surgery and in dermatology and Electrosurgical cutting and
coagulation device and accessories.
Product code: GEX, PBX, ISA
Regulation No: 21 CFR878.4810, 21CFR878.4400
Class: II
Panel: General and plastic surgery devices |
| Predicate
Device(s): | Viora V-total system (K133837)
Viora V20 system (K152611)
Viora V10 system (K150035) |
5
Image /page/5/Picture/0 description: The image shows the logo for VIORA. The logo consists of a stylized infinity symbol above the word "VIORA" in a bold, sans-serif font. Below the word "VIORA" is the tagline "Shape the Future" in a smaller, lighter font. The logo is simple, modern, and professional.
Device description
The Viora V30 system is a multi-application, multi-technology platform device intended for use in dermatologic procedures.
The main console unit incorporates a touch-screen control panel, power supply modules, cooling system, switching module and service panel. The system includes four Handpieces and footswitch. The V30 system is cooled by deionized water. The Viora V30 system is available with four treatment Handpieces:
- V-ST Handpiece Bi-polar radiofrequency (RF) Handpiece .
- V-IPL Handpiece Intense pulsed light (IPL) Handpiece ●
- V-ND:YAG Handpiece Long pulse neodymium-doped yttrium aluminum ● laser Handpiece
- V Form Handpiece with BC Small, BC Medium and BC Large applicators .
The V- Form BC Medium applicator is Bi-polar radiofrequency (RF) applicator.
The applicator is supported by Viora's V10, V20 and V30 systems.
Intended use and indication for use statement
The Viora V30 system is intended for dermatological procedures.
The V-ST Handpiece is indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation.
The V-IPL Handpiece with wavelengths 415-1200nm (with 5 different filters) is
indicated for the treatment of:
- · Moderate inflammatory acne vulgaris.
- · Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles).
- · Cutaneous lesions including warts, scars and striae.
6
Image /page/6/Picture/0 description: The image shows the logo for VIORA. The logo consists of a stylized infinity symbol above the word "VIORA" in a bold, sans-serif font. Below the word "VIORA" is the tagline "Shape the Future" in a smaller, lighter font.
- · Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte and venous malformations.
- · Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen.
The V-Nd:YAG Handpiece with wavelength 1064 nm comes with 4 different applicator spot diameters: 2x4, 3.5, 5.5 and 9.5 mm.
The three smaller spot sizes (2x4, 3.5, 5.5 mm) are intended for:
- · Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias), reticular veins (0.1-4.0 mm dia.) of the leg, rosacea, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas.
- Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis.
- · Benign pigmented lesions such as, but not limited to: lentigos (age spots), solar lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of Ota, chloasma, verrucae, skin tags and keratosis.
- · Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments.
- The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles and perioral wrinkles.
The Handpiece with a spot size of 9.5 mm is also intended for treatment of:
- · Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar.
7
Image /page/7/Picture/0 description: The image shows the logo for VIORA. The logo consists of the word "VIORA" in a bold, sans-serif font, with the tagline "Shape the Future" in a smaller, lighter font underneath. Above the word "VIORA" is a stylized graphic that resembles an infinity symbol with a curved line extending from the top left.
- · The Handpiece with a spot size of 9.5 mm is also is intended for removal of unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen
and treatment of pseudofolliculitis barbae (PFB).
The V-Form Handpiece (with BC Small, Medium and Large applicators) is indicated for delivering non thermal RF combined with massage:
- · relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation and
- · temporary reduction in the appearance of cellulite.
The Viora V20 and V10 systems with V-Form Handpiece (with BC Small,
Medium and Large applicators) are indicated for delivering non thermal RF combined with massage:
- · relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation and
- · temporary reduction in the appearance of cellulite.
Predicade Devices
The predicate devices for Viora V30 system with V-Form Handpiece for this Premarket Notification are the following:
| Device Name | 510k No. | Date of Clearance |
|---|---|---|
| Viora V-total (V30 | ||
| system) | K133837 | April 9, 2014 |
| Viora V20 system | K152611 | February 19, 2016 |
The Predicate devices for V- Form BC Medium applicator are:
| Device name | 510k No. | Date of Clearance |
|---|---|---|
| Viora V20 system | K152611 | February 19, 2016 |
| Viora V10 system | K150035 | May 1, 2015 |
8
Image /page/8/Picture/0 description: The image shows the logo for VIORA. The logo consists of a stylized infinity symbol above the word "VIORA" in a bold, sans-serif font. Below the word "VIORA" is the tagline "Shape the Future" in a smaller, lighter font. The logo is black and white.
Substantial Equivalence to Predicate Device
The V30 system with the V- Form Handpiece and its predicate devices have the same intended use and the same indications for use. The proposed V-ST, V-IPL and V-Nd: YAG Handpieces have the same technological characteristics and the same performance characteristics as the cleared Viora V-total ST, IPL and Nd:Yag Laser Handpieces (K133837). Therefore, no new safety or efficacy issues can be raised. The Viora V30 V-Form Handpiece is exactly the same as the cleared Viora V20 V-Form Handpiece (K152611)). The V-Form Handpiece has the same technological characteristics and the same performance as the predicate device. Therefore, no new safety or efficacy issues can be raised.
Any differences in the software and in the system design do not raise any new issues of safety and effectiveness, as was verified by performance testing. Therefore, the V30 system with the V- Form Handpiece is substantially equivalent to its predicate devices.
The V-Form Handpiece BC Medium Applicator and the Viora V- Form BC Large Applicator (K152611, K150035) have identical intended use and similar technological features. Any differences in the V-Form Handpiece design do not raise any new questions of safety and effectiveness, as verified by performance testing. Therefore, the V-Form Handpiece BC Medium Applicator is substantially equivalent to its predicate devices.
Performance standards
The V30 system complies with:
- . IEC 60601-1: Medical Electrical Equipment - Part 1: General Requirements For Basic Safety And Essential Performance.
- . IEC 60601-1-2: Medical Electrical Equipment - Part 1-2: General Requirements For Basic Safety And Essential Performance - Collateral Standard: Electromagnetic Compatibility - Requirements And Tests.
9
Image /page/9/Picture/0 description: The image shows the logo for VIORA. The logo consists of a stylized infinity symbol above the word "VIORA" in a bold, sans-serif font. Below the word "VIORA" is the tagline "Shape the Future" in a smaller, lighter font. The logo is simple, modern, and professional.
- IEC 60601-2-2: Medical Electrical Equipment Part 2-2: Particular . Requirements For The Basic Safety And Essential Performance Of High Frequency Surgical Equipment And High Frequency Surgical Accessories.
- IEC 60601-2-57: Particular Requirements For The Basic Safety And Essential . Performance Of Non-Laser Light Source Equipment Intended For Therapeutic, Diagnostic, Monitoring And Cosmetic/Aesthetic Use.
- IEC 60601-2-22: Particular Requirements For Basic Safety And . Essential Performance of Surgical, Cosmetic, Therapeutic And Diagnostic Laser Equipment.
- IEC 60825-1: Safety of Laser Products Part 1: Equipment Classification, . And Requirements
The Viora V20 and V10 systems with V-Form Handpiece BC Medium applicator comply with:
- . IEC 60601-1: Medical Electrical Equipment - Part 1: General Requirements For Basic Safety And Essential Performance.
- . IEC 60601-1-2: Medical Electrical Equipment - Part 1-2: General Requirements For Basic Safety And Essential Performance - Collateral Standard: Electromagnetic Compatibility - Requirements And Tests.
- IEC 60601-2-2: Medical Electrical Equipment Part 2-2: Particular . Requirements For The Basic Safety And Essential Performance Of High Frequency Surgical Equipment And High Frequency Surgical Accessories.
Performance Bench Tests
Bench testing demonstrated that the V30 system (with the V- Form Handpiece) and the V-Form Handpice BC Medium applicator are as safe and effective as the cleared predicate devices.
10
Image /page/10/Picture/0 description: The image shows the logo for VIORA. The logo consists of a stylized infinity symbol above the word "VIORA" in a bold, sans-serif font. Below the word "VIORA" is the tagline "Shape the Future" in a smaller, lighter font.
Pre-Clinical and clinical study
Since the technological parameters of the Viora V30 system with the V- Form Handpiece and of the V-Form Handpice BC Medium applicator are well within the parameters of the previously cleared V-total, V20 and V10 systems, Viora believes that animal and clinical studies are not required to determine the safety and efficacy of the V30 system with the V- Form Handpiece and of the V-Form Handpice BC Medium applicator.
Conclusion
Based on the technological characteristics of the devices and the intended use, Viora believes that the V30 system with the V- Form Handpiece and the V-Form Handpice BC Medium applicator are substantially equivalent to the predicate devices. The differences do not raise any new issues of safety or effectiveness.